Ernexa Therapeutics Inc. Dividend Income, Operating
Ernexa Therapeutics Inc. (ERNA) reported Dividend Income, Operating of $16.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DividendIncomeOperating · last filed 2019-03-22
- Ernexa Therapeutics Inc. dividend income, operating for fiscal 2018 was $16.00K, a 0.00% change from fiscal 2017.
- Ernexa Therapeutics Inc. dividend income, operating for fiscal 2017 was $16.00K.
| Period end | Dividend Income, Operating 12 month |
|---|---|
| 2018-12-31 | $16.00K 10-K · filed 2019-03-22 |
| 2017-12-31 | $16.00K 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |